Predictors of acute esophagitis in patients with non-small-cell lung carcinoma treated with concurrent chemotherapy and hyperfractionated radiotherapy followed by surgery.
about
Clinical and dosimetric factors of radiation-induced esophageal injury: radiation-induced esophageal toxicity.Normal tissue complication models for clinically relevant acute esophagitis (≥ grade 2) in patients treated with dose differentiated accelerated radiotherapy (DART-bid).Intraesophageal administration of GS-nitroxide (JP4-039) protects against ionizing irradiation-induced esophagitisGastrointestinal radiation injury: symptoms, risk factors and mechanismsDose-volumetric parameters and prediction of severe acute esophagitis in patients with locally-advanced non small-cell lung cancer treated with neoadjuvant concurrent hyperfractionated-accelerated chemoradiotherapy.Modeling the risk of radiation-induced acute esophagitis for combined Washington University and RTOG trial 93-11 lung cancer patientsRadiation-induced esophagitis in lung cancer.Esophagitis, treatment-related toxicity in non-small cell lung cancer.Independent test of a model to predict severe acute esophagitis.Persistence of dysphagia and odynophagia after mediastinal radiation and chemotherapy in patients with lung cancer or lymphoma.Is there a selection bias in radiotherapy dose-escalation protocols?Prediction of Radiation Esophagitis in Non-Small Cell Lung Cancer Using Clinical Factors, Dosimetric Parameters, and Pretreatment Cytokine Levels.Digestive toxicities after palliative three-dimensional conformal radiation therapy (3D-CRT) for cervico-thoracic spinal metastases.A model combining age, equivalent uniform dose and IL-8 may predict radiation esophagitis in patients with non-small cell lung cancer.
P2860
Q35010640-F06AB449-8B7C-4303-891E-54724D4572F6Q35669846-0963007E-97C6-400D-BD79-C39774AB285BQ36464619-03F5A82C-119F-482E-A9FD-B8D1C0ED155FQ36541173-F3B05FF0-7FA9-4393-9311-E5733E70C0F7Q36958517-476CCC64-7D8E-4686-87DA-71AFF840E492Q37199630-1EE770A1-DE81-41C7-A6B6-C24EC8DC6993Q37643563-6CA4B2A4-9E1A-4B19-898C-6287A9F6A2CBQ37921816-BDF8AC42-F5CD-42F8-A187-7F3AC9DC4D43Q38663190-BEF88E4B-743E-49A3-89E7-1014C44B27C1Q39720229-76654231-9A17-4C69-A255-B91B9A2823B2Q42610923-A197B65C-74A0-43FB-B03E-DF387D9F30D8Q47342475-C282221C-E59B-491E-A03E-64342E327FC1Q48351096-BA7C2890-1150-46B1-B05E-54793E0C01FDQ55279852-FC52C7F1-9FB7-4039-B15A-B9EC42DBD9A6
P2860
Predictors of acute esophagitis in patients with non-small-cell lung carcinoma treated with concurrent chemotherapy and hyperfractionated radiotherapy followed by surgery.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Predictors of acute esophagiti ...... iotherapy followed by surgery.
@en
Predictors of acute esophagiti ...... iotherapy followed by surgery.
@nl
type
label
Predictors of acute esophagiti ...... iotherapy followed by surgery.
@en
Predictors of acute esophagiti ...... iotherapy followed by surgery.
@nl
prefLabel
Predictors of acute esophagiti ...... iotherapy followed by surgery.
@en
Predictors of acute esophagiti ...... iotherapy followed by surgery.
@nl
P2093
P1476
Predictors of acute esophagiti ...... iotherapy followed by surgery.
@en
P2093
Ashish B Patel
Mark J Krasna
Martin J Edelman
Mohan Suntharalingam
Young Kwok
P304
P356
10.1016/J.IJROBP.2004.04.051
P407
P577
2004-11-01T00:00:00Z